1. Home
  2. NSIT vs ADMA Comparison

NSIT vs ADMA Comparison

Compare NSIT & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insight Enterprises Inc.

NSIT

Insight Enterprises Inc.

HOLD

Current Price

$107.10

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$8.02

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSIT
ADMA
Founded
1988
2004
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
1996
2012

Fundamental Metrics

Financial Performance
Metric
NSIT
ADMA
Price
$107.10
$8.02
Analyst Decision
Hold
Strong Buy
Analyst Count
4
4
Target Price
$116.25
$25.67
AVG Volume (30 Days)
570.8K
6.0M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.97
0.19
Revenue
$8,247,180,000.00
$42,219,783.00
Revenue This Year
$3.79
$27.46
Revenue Next Year
$2.16
$22.11
P/E Ratio
$106.29
$41.53
Revenue Growth
N/A
43.85
52 Week Low
$63.62
$7.21
52 Week High
$148.36
$22.37

Technical Indicators

Market Signals
Indicator
NSIT
ADMA
Relative Strength Index (RSI) 83.34 32.24
Support Level $105.78 $7.34
Resistance Level $111.54 $11.42
Average True Range (ATR) 4.28 0.32
MACD 1.91 0.03
Stochastic Oscillator 97.04 20.92

Price Performance

Historical Comparison
NSIT
ADMA

About NSIT Insight Enterprises Inc.

Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, government agencies, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital workplace, cloud/data center transformation, IT modernization, Cyber Security and supply chain optimization solutions and services.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: